Reproductive and exogenous hormone factors in relation to risk of meningioma in women: A meta-analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Qi, Zhen Yu ^a   Shao, Chuan ^a   Huang, Yu Lun ^a   Hui, Guo Zhen ^a   Zhou, You Xin ^a   Wang, Zhong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGE FACTORS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENINGIOMA; PARITY; POSTMENOPAUSE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; WOMEN;

EID: 84893534416     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083261     Document Type: Article

References (56)

1. Sanson M, Cornu P (2000) Biology of meningiomas. Acta Neuro chir (Wien) 142:493-505. (Pubitemid 30303753)
2. Maiuri F, De Caro ML, de Divitiis O, Vergara P, Mariniello G (2011) Spinal meningiomas: age-related features. Clin Neurol Neurosurg113:34-38.
3. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278-299.
4. McKinney PA (2004) Brain tumours: incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry 75:ii12-ii17.
5. Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma.J Neurooncol 99:307-314.
6. Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86:113-120. (Pubitemid 27009982)
7. Rubinstein AB, Loven D, Geier A, Reichenthal E, Gadoth N (1994) Hormone receptors in initially excised versus recurrent intracranial meningiomas. J Neurosurg 81:184-187. (Pubitemid 24237995)
8. Jay JR, MacLaughlin DT, Riley KR, Martuza RL (1985) Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62:757-762. (Pubitemid 15091458)
9. Hatiboglu MA, Cosar M, Iplikcioglu AC, Ozcan D (2008) Sex steroid and epidermal growth factor profile of giant meningiomas associated with pregnancy. Surg Neurol 69:356-362. (Pubitemid 351400797)
10. Smith JS, Quiñones-Hinojosa A, Harmon-Smith M, Bollen AW, McDermott MW (2005) Sex steroid and growth factor profile of a meningioma associated with pregnancy. Can J Neurol Sci 32:122-127. (Pubitemid 40363591)
11. Custer BS, Koepsell TD, Mueller BA (2002)The association between breast carcinoma and meningioma in women.Cancer 94:1626-1635. (Pubitemid 34241097)
12. Rao G, Giordano SH, Liu J, McCutcheon IE (2009) The association of breast cancer and meningioma in men and women. Neurosurgery 65:483-489.
13. Preston-Martin S, Monroe K, Lee PJ, Bernstein L, Kelsey J, et al. (1995) Spinal meningiomas in women in Los Angeles County: investigation of an etiological hypothesis.Cancer Epidemiol Biomarkers Prev 4:333-339.
14. Lambe M, Coogan P, Baron J (1997) Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer 72:389-393. (Pubitemid 27325862)
15. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, et al. (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82:155-160. (Pubitemid 29293770)
16. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ (2003) Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99:848-853. (Pubitemid 37314920)
17. Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, et al.(2005) Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 114:797-805. (Pubitemid 40344441)
18. Lee E, Grutsch J, Persky V, Glick R, Mendes J, et al. (2006) Association of meningioma with reproductive factors. Int J Cancer 119:1152-1157. (Pubitemid 44116925)
19. Custer B, Longstreth WT Jr, Phillips LE, Koepsell TD, Van Belle G (2006) Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 6:152.
20. Wigertz A, Lönn S, Mathiesen T, Ahlbom A, Hall P, et al. (2006) Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164:629-636. (Pubitemid 44453491)
21. Benson VS, Pirie K, Green J, Casabonne D, Beral V, et al. (2008) Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 99:185-190.
22. Wigertz A, Lönn S, Hall P, Auvinen A, Christensen HC, et al. (2008) Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 17:2663-2670.
23. Benson VS, Pirie K, Green J, Bull D, Casabonne D, et al. (2010) Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study. Int J Cancer 127:1692-1698
24. Korhonen K, Raitanen J, Isola J, Haapasalo H, Salminen T, et al. (2010) Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control 21:2149-2156.
25. Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, et al. (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev19:2562-2569.
26. Johnson DR, Olson JE, Vierkant RA, Hammack JE, Wang AH, et al. (2011) Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study. Neuro Oncol 13:1011-1019.
27. Cea-Soriano L, Blenk T, Wallander MA, Rodríguez LA (2013) Hormonal therapies and meningioma: is there a link? Cancer Epidemiol 36:198-205.
28. Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, et al. (2013) Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg 118:649-656.
29. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
30. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. (Pubitemid 34746062)
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560. (Pubitemid 37088507)
32. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
33. Blitshteyn S, Crook JE, Jaeckle KA (2008) Is there an association between meningioma and hormone replacement therapy? J Clin Oncol 26:279-282.
34. Schlehofer B, Blettner M, Wahrendorf J (1992) Association between brain tumors and menopausal status. J Natl Cancer Inst 84:1346-1349.
35. Ryan P, Lee MW, North B, McMichael AJ (1992) Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 51:20-27.
36. [No authors listed] (2010) Postmenopausal hormone replacement therapy and meningioma.Prescrire Int 19:120.
37. Hunt K, Vessey M, McPherson K, Coleman M (1987) Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 94:620-635. (Pubitemid 17093778)
38. Hunt K, Vessey M, McPherson K. (1990) Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 97:1080-1086.
39. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L (1989) Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 44:833-839. (Pubitemid 20007980)
40. Plesko I, Preston-Martin S, Day NE, Tzonou A, Dimitrova E, et al. (1985) Parity and cancer risk in Slovakia.Int J Cancer 36:529-533. (Pubitemid 16233509)
41. Cantor KP, Lynch CF, Johnson D (1993) Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 4:505-511. (Pubitemid 24065288)
42. Persson I, Yuen J, Bergkvist L, Schairer C (1996) Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy-long-term follow-up of a Swedish cohort. Int J Cancer 67:327-332. (Pubitemid 26274121)
43. Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, et al. (2007) Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ 335:651.
44. Chiu HF, Chen CC, Tsai SS, Ho SC, Yang CY (2012) Parity, age at first birth, and risk of death from brain cancer: a population-based cohort study in Taiwan. BMC Public Health 12:857.
45. Korhonen K, Auvinen A, Lyytinen H, Ylikorkala O, Pukkala E (2012) A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.Am J Epidemiol 175:309-314.
46. Andersen L, Friis S, Hallas J, Ravn P, Schrøder HD, et al. (2013) Hormone replacement therapy increases the risk of cranial meningioma. Eur J Cancer 49:3303-3310.
47. Duval S, Tweedie R (2000) A non-parametric "trim and fill" method of accounting for publication bias in meta-analysis. J Am Stat Assoc 95: 89-98.
48. Fan ZX, Shen J, Wu YY, Yu H, Zhu Y, et al. (2013) Hormone replacement therapy and risk of meningioma in women: a meta-analysis. Cancer Causes Control 24:1517-25.
49. Cowppli-Bony A, Bouvier G, Rué M, Loiseau H, Vital A, et al. (2011) Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22:697-714.
50. Chamoun R, Krisht KM, Couldwell WT (2011) Incidental meningiomas. Neurosurg Focus 31:E19.
51. Aghi MK, Eskandar EN, Carter BS, Curry WT Jr, Barker FG 2nd (2007) Increased prevalence of obesity and obesity-related postoperative complications in male patients with meningiomas. Neurosurgery 61:754-760. (Pubitemid 350073272)
52. Basen-Engquist K, Chang M (2011) Obesity and cancer risk: recent review and evidence. Curr Oncol Rep13:71-76.
53. Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301-316.
54. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569-578. (Pubitemid 351232031)
55. Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21:427-433. (Pubitemid 30137927)
56. Dickson RB, Stancel GM (2000) Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr 27:135-145.